0001209191-21-045825.txt : 20210707
0001209191-21-045825.hdr.sgml : 20210707
20210707164635
ACCESSION NUMBER: 0001209191-21-045825
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210702
FILED AS OF DATE: 20210707
DATE AS OF CHANGE: 20210707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scavilla Daniel T
CENTRAL INDEX KEY: 0001642439
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35621
FILM NUMBER: 211077911
MAIL ADDRESS:
STREET 1: C/O GLOBUS MEDICAL, INC.
STREET 2: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLOBUS MEDICAL INC
CENTRAL INDEX KEY: 0001237831
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043744954
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
BUSINESS PHONE: 610-930-1800
MAIL ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-02
0
0001237831
GLOBUS MEDICAL INC
GMED
0001642439
Scavilla Daniel T
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
AUDUBON
PA
19403
0
1
0
0
EVP, Chief Commercial Officer
Class A Common Stock
2021-07-02
4
M
0
50000
25.52
A
50000
D
Class A Common Stock
2021-07-02
4
M
0
50000
26.27
A
100000
D
Class A Common Stock
2021-07-02
4
S
0
99600
78.41
D
400
D
Class A Common Stock
2021-07-02
4
S
0
400
78.97
D
0
D
Stock Option (Right to buy Class A Common Stock)
25.52
2021-07-02
4
M
0
50000
0.00
D
2026-01-25
Class A Common Stock
50000
0
D
Stock Option (Right to Buy Class A Common Stock)
26.27
2021-07-02
4
M
0
50000
0.00
D
2027-01-30
Class A Common Stock
50000
30000
D
This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.83 to $78.69, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
/s/ Kelly G. Huller, Attorney-in-Fact
2021-07-07